# RVL Pharmaceuticals plc — Form D

RVL Pharmaceuticals plc of BRIDGEWATER, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-31. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2023-08-31
- Form: D
- Accession: 0001739426-23-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 1
- Date of first sale: 2023-08-18
- Revenue range: Decline to Disclose
- SEC file number: 021-491138

## Issuer

- Name: RVL Pharmaceuticals plc
- CIK: 0001739426
- Entity type: Other
- Jurisdiction: IRELAND
- Address: 400 CROSSING BOULEVARD, BRIDGEWATER, NJ, 08807
- Phone: 908-809-1300

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| JOAQUIN BENES | Director | BRIDGEWATER, NJ |
| GREGORY COWAN | Director | BRIDGEWATER, NJ |
| MICHAEL DEBIASI | Director | BRIDGEWATER, NJ |
| ALISA LASK | Director | Rehovot, L3 |
| BRIAN MARKISON | Director | ROCKVILLE, MD |
| JUAN VERGEZ | Director | BRIDGEWATER, NJ |
| BRIAN MARKISON | Executive Officer | ROCKVILLE, MD |
| JAMES SCHAUB | Executive Officer | BRIDGEWATER, NJ |

## More

- [CIK 1739426 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1739426&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001739426-23-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.